This inventor holds 1 USPTO granted patent. Top assignees: Kyungpook National University Industry-Academic Cooperation Foundation, Seoul National University. Active years: 2016.
Company Filing History:
2 out of 363 
1 out of 1,774 
Years Active: 2016
Title: The Innovations of Donghyun Lim
Introduction
Donghyun Lim is a notable inventor based in Gwangju, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-inflammatory compositions. His work is characterized by a focus on innovative compounds that address critical health issues.
Latest Patents
Donghyun Lim holds a patent for an anti-inflammatory pharmaceutical composition comprising benzopyranyl tetracycles. This composition is disclosed as an effective treatment for inflammation-related diseases. The active ingredient, represented by Chemical Formula 1, demonstrates excellent anti-inflammatory activity by perturbing the post-translational modification of the inflammation mediator HMGB. This innovation has the potential to enhance pharmaceutical compositions aimed at treating or preventing inflammation.
Career Highlights
Throughout his career, Donghyun Lim has been associated with prestigious institutions such as the Kyungpook National University Industry-Academic Cooperation Foundation and Seoul National University. His work in these organizations has allowed him to advance his research and contribute to the scientific community.
Collaborations
Donghyun Lim has collaborated with esteemed colleagues, including Seung Bum Park and Sanghee Lee. These partnerships have fostered a collaborative environment that enhances the quality and impact of his research.
Conclusion
Donghyun Lim's innovative work in the field of anti-inflammatory pharmaceuticals showcases his dedication to improving health outcomes. His contributions are significant and reflect a commitment to advancing medical science.